High levels of P2RX5 expression predicts a poor prognosis and promotes tumor progression in endometrial cancer
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
OBJECTIVE: This study aims to investigate the impact of P2RX5 on the clinical pathological characteristics and prognosis of endometrial carcinoma, and to explore its potential underlying mechanisms. METHODS: The clinical samples, including 150 specimens with endometrial carcinoma (Case group) and 100 endometrial samples without cancer (Control group), were collected for analyzing the amount of P2RX5 expression. Cell biology experiments were also used for exploring the effects of P2RX5 expression on biological behaviors of endometrial carcinoma. RESULTS: < 0.05). CONCLUSION: These findings suggest a critical role of P2RX5 in endometrial cancer progression and thereby establish the value of P2RX5 as a prognostic biomarker and provide a promising therapeutic target for endometrial cancer treatment.
Fields of Study & Subjects
Adenosine and Purinergic Signaling
Endometrial and Cervical Cancer Treatments
Breast Cancer Treatment Studies
Publication details
- Journal / source
- International Journal of Clinical and Experimental Pathology
- Volume
- 19
- Issue
- 3
- Pages
- 146–159
- Publication date
- 1 January 2026
- Language
- EN